- 貨號 Cat. No.
- S7319
- 規格 Size
- 10mgã€25mg
- 品牌 Brand
- Selleckchem
Description
EHop-016
Catalog No.S7319
EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1, equally potent inhibition for Rac3.
Size |
Price |
Stock |
Quantity |
|
|---|
10mg |
USD 122 |
In stock |
0
1
2
3
4
5
6
7
8
9
10
|
25mg |
USD 214 |
In stock |
0
1
2
3
4
5
6
7
8
9
10
|
|
Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw
Biological Activity
Description |
EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1, equally potent inhibition for Rac3. |
|---|
Targets |
Rac1 |
|
|
|
|
|
|---|
IC50 |
1.1 μM [1] |
|
|
|
|
|
|---|
In vitro |
Rac inhibition by EHop-016 increases the activity of the closely related Rho GTPase RhoA by a compensatory mechanism. In MDA-MB-435 cells, EHop-016 (2-5 μM) inhibits association of active Vav2 with Rac1(G15A) mutant fusion protein, and reduces Rac-regulated cell functions including lamellipodia formation and cell migration. In addition, EHop-016 inhibits cell viability of MDA-MB-435 cells with IC50 of 10 μM. [1] EHop-016 also inhibits KITD814V-induced growth in SM and AML patients-derived cells. [2] |
|---|
In vivo |
Treatment of KITD814V-bearing cells with EHop-016 significantly enhances the survival of leukemic mice. [2] |
|---|
Features |
|
|---|
Protocol(Only for Reference)
Kinase Assay: [1]
Rac Activity Assays |
Rac activity is determined from lysates of the MDA-MB-435 and MDA-MB-231 human metastatic cancer cell lines (from ATCC). Cancer cells in culture medium (DMEM, 10% FBS, pH 7.5) are treated with vehicle (0.1% DMSO) or varying concentrations of EHop-016 (0–10 μM) for 24 h. Rac1 activity is determined using the G-LISA Rac1 activation assay kit. |
|---|
Cell Assay: [1]
Cell lines |
MDA-MB-231, MDA-MB-435, or MCF-10A cells |
|---|
Concentrations |
~10 μM |
|---|
Incubation Time |
24 hours |
|---|
Method |
MDA-MB-231, MDA-MB-435, or MCF-10A mammary epithelial cells (from ATCC) are incubated in vehicle (0.1% DMSO) or varying concentrations of EHop-016 (0–10 μM) for 24 h. Cell viability is measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell survival and proliferation kit according to the manufacturer’s instructions. |
|---|
Animal Study: [2]
Animal Models |
KITD814V-bearing mice. |
|---|
Dosages |
2.5 μM |
|---|
Administration |
KITD814V-bearing 32D cells with EHop-016 are administered by i.v. injection. |
|---|
Solubility |
1% DMSO/30% polyethylene glycol/1% Tween 80, 30 mg/mL |
|---|
1
References
Download EHop-016 SDF
Molecular Weight (MW) |
430.55 |
|---|
Formula |
C25H30N6O
|
|---|
CAS No. |
1380432-32-5 |
|---|
Storage |
3 years -20℃Powder |
|---|
6 months-80℃in DMSO |
Syonnyms |
N/A |
|---|
Solubility (25°C) * |
In vitro |
DMSO |
86 mg/mL (199 mM) |
|---|
Water |
<1 mg/mL (<1 mM) |
Ethanol |
<1 mg/mL (<1 mM) |
In vivo |
1% DMSO/30% polyethylene glycol/1% Tween 80, |
30 mg/mL |
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name |
N4-(9-Ethyl-9H-carbazol-3-yl)-N2-(3-morpholin-4-yl-propyl)-pyrimidine-2,4-diamine |
|---|
詢價 / 洽詢此產品